Oxford Biomedica Share News (OXB)

Oxford BioMedica sells Windrush court facility for GBP60 million

(Alliance News) - Oxford BioMedica PLC announced on Monday it had exchanged contracts for the sale and leaseback of its Windrush Court facility to Kadans Science Partner for GBP60 million.

SMALL-CAP WINNERS & LOSERS: ME Group upgrades outlook on robust demand

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

SMALL-CAP WINNERS & LOSERS: Superdry swings to profit; Halfords falls

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Oxford Biomedica extends Oaktree relationship with new loan facility

(Alliance News) - Oxford Biomedica PLC on Friday said that it has completed the partial repayment and amendment of its Oaktree Capital Management LP loan facility, as it looks to extend its relationship with the US banking company further.

SMALL-CAP WINNERS & LOSERS: Capita buoyed by contract win and disposal

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Oxford Biomedica swings to loss as Covid vaccine winds down

(Sharecast News) - Oxford Biomedica reported a 21% decrease in its first-half total revenue on Thursday, to £64m.

Oxford BioMedica swings to interim loss as costs climb, revenue falls

(Alliance News) - Oxford BioMedica PLC on Thursday reported a swing to interim loss and a decline in interim revenue.

IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an unnamed new partner, for an undisclosed sum. Says the deal gives the US-based, private biotechnology firm access to Oxford BioMedica Solutions's process and manufacturing platform.

UK earnings, trading statements calendar - next 7 days

Oxford BioMedica shares up as license deal signed with new US partner

(Alliance News) - Oxford BioMedica PLC on Wednesday said it signed a license and supply agreement with an unnamed new partner.

Oxford Biomedica inks LSA with new US biotech partner

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has struck a new licence and supply agreement with an unnamed US partner.

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

SMALL-CAP WINNERS & LOSERS: Reach and Wickes sink on dark outlook

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Oxford BioMedica begins new project and signs license agreement

(Alliance News) - Oxford BioMedica PLC on Tuesday said it started a new project and signed a license and supply agreement.